TipRanks
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market
VRAX
Virax Biolabs Group Ltd. Class A
RESEARCH TOOLSreports

Virax Biolabs Group Ltd. Class A (VRAX) Balance Sheet

171 Followers

Virax Biolabs Group Ltd. Class A Balance Sheet

Virax Biolabs Group Ltd. Class A's total assets for Q4 2026 were $8.32M, an increase of 45.66% from the previous quarter. VRAX total liabilities were $989.83K for the fiscal quarter, a 54.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 26Mar 25Mar 24Mar 23Sep 22
Total Assets
$ 8.32M$ 6.43M$ 5.48M$ 9.81M$ 48.71K
Total Liabilities
$ 989.83K$ 964.75K$ 345.19K$ 908.40K$ 1.25M
Total Equity Gross Minority
$ 7.33M$ 5.46M$ 5.14M$ 8.90M$ -1.20M
Other Metrics
Currency in USD

Virax Biolabs Group Ltd. Class A Debt to Assets